Makary Calls for “New FDA” at BIO; Defends Agency’s Spring Job Cuts

Makary Calls for “New FDA” at BIO; Defends Agency’s Spring Job Cuts

BOSTON—FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA”—one that would decide on drug applications much faster, partner with industry, and apply artificial intelligence (AI) and big data—with biopharma leaders attending the Biotechnology Innovation Organization (BIO) International Convention, being held at the Boston Convention and Exhibition Center. “Our focus in this FDA is very clear: Call it a New FDA. We’re going to use…